Acute Biphenotypic Leukemia (ABL) Recruiting Phase 2 Trials for Azacitidine (DB00928)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Recruiting2 IdentifierTitlePurposeDrugs
NCT02397720Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid LeukemiaTreatment
NCT03683433Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene MutationTreatment